Current trends in Cancer Research and Immuno-Oncology
Journal of Cancer Research and Immuno-Oncology is one of the most promising and rapidly developing areas of cancer research. The journal focuses on the development of new therapies which improve human body’s immune response against cancer.Journal of Cancer Research and Immuno-Oncology covers a broad scope for the authors to make their valuable contributions in the area of cancer biology, tumor and stem cell biology, immunology, microenvironment and immunology, molecular and cellular pathobiology, immuno-oncology, prevention and epidemiology, therapeutics and targets.
Journal of Cancer Research and Immuno-Oncology is focused on publishing articles on various areas of immunotherapy like cancer immunotherapy, tumor immunology, immune system, nucleic acid research, immune suppression, immunosurveillance, tumor immunity, cellular immunotherapy, cancer radioimmunotherapy, cancer immunology, cancer immunoediting, immunotherapeutics, immunogenicity and recent research in these areas. The Journal provides an open access platform to publish latest advancements in all aspects related to immune-oncology.
This Journal provides a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on any array of latest cancer research and Immuno-Oncology. The Journal of Cancer Research and Immuno-Oncology is a Peer Reviewed Open Access Journal supported by universally prominent Editorial Board members. Abstracts and full texts of all articles published by Journal of Cancer Research and Immuno-Oncology are freely accessible to everyone immediately after publication.
The journal is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking system. Review processing is performed by the editorial board members of Journal of Cancer Research and Immuno-Oncology or outside experts; approval of at least two independent reviewers followed by the editor is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process
Journal of Cancer Research and Immuno-oncology